Compile Data Set for Download or QSAR
maximum 50k data
Found 53 Enz. Inhib. hit(s) with all data for entry = 1512
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328390(3-(difluoromethyl)-6-fluoro-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.0660nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328384(3-(difluoromethyl)-5-fluoro-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.0740nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328391(6-chloro-3-(difluoromethyl)-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  0.0850nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328394(3-(difluoromethyl)-6-bromo-1-((4-methoxy-3-(4-meth...)
Affinity DataIC50:  0.0900nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328397(6-chloro-3-(difluoromethyl)-1-((3-(4-isopropylpipe...)
Affinity DataIC50:  0.0900nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328396(6-chloro-1-((3-(4-cyclopropylpiperazin-1-yl)-4-met...)
Affinity DataIC50:  0.0920nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328392(3-(difluoromethyl)-6-chloro-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.100nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328395(6-chloro-3-(difluoromethyl)-1-((3-(4-ethylpiperazi...)
Affinity DataIC50:  0.130nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328400(3-(difluoromethyl)-1-((4-methoxy-3-(4-methylpipera...)
Affinity DataIC50:  0.140nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328380(6-chloro-1-((4-methoxy-3-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  0.140nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328381(6-bromo-1-((4-methoxy-3-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50:  0.170nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328388(3-(difluoromethyl)-5-bromo-1-((4-methoxy-3-(4-meth...)
Affinity DataIC50:  0.200nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328379(6-chloro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  0.210nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328386(5-chloro-3-(difluoromethyl)-1-((4-methoxy-3-(4-met...)
Affinity DataIC50:  0.220nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328401(3-(difluoromethyl)-1-((3-(4-ethylpiperazin-1-yl)-4...)
Affinity DataIC50:  0.25nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328389(3-(difluoromethyl)-6-fluoro-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  0.260nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328393(3-(difluoromethyl)-6-bromo-1-((4-methoxy-3-(pipera...)
Affinity DataIC50:  0.330nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328399(3-(difluoromethyl)-1-((4-methoxy-3-(piperazin-1-yl...)
Affinity DataIC50:  0.400nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328402(1-((3-(4-cyclopropylpiperazin-1-yl)-4-methoxypheny...)
Affinity DataIC50:  0.400nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328366(4-fluoro-1-((4-methoxy-3-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  0.430nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328408(5-fluoro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  0.430nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328412(6-chloro-3-ethyl-1-((4-methoxy-3-(piperazin-1-yl)p...)
Affinity DataIC50:  0.450nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328383(3-(difluoromethyl)-5-fluoro-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  0.460nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328398(6-chloro-1-((3-(4-cyclobutylpiperazin-1-yl)-4-meth...)
Affinity DataIC50:  0.5nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328404(5,6-dichloro-3-(difluoromethyl)-1-((4-methoxy-3-(p...)
Affinity DataIC50:  0.540nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328387(5-bromo-3-(difluoromethyl)-1-((4-methoxy-3-(pipera...)
Affinity DataIC50:  0.550nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328382(7-fluoro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  0.570nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328407(6-bromo-3-(difluoromethyl)-1-((4-methoxy-3-(pipera...)
Affinity DataIC50:  0.580nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328362(1-((4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)sul...)
Affinity DataIC50:  0.590nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328413(6-bromo-3-ethyl-1-((4-methoxy-3-(piperazin-1-yl)ph...)
Affinity DataIC50:  0.600nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328411(3-ethyl-6-fluoro-1-((4-methoxy-3-(piperazin-1-yl)p...)
Affinity DataIC50:  0.630nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328385(5-chloro-3-(difluoromethyl)-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  0.640nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328409(5-chloro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  0.670nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328378(6-fluoro-1-((4-methoxy-3-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  0.670nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328364(1-(1-((4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)...)
Affinity DataIC50:  0.870nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328410(5-bromo-1-((4-methoxy-3-(piperazin-1-yl)phenyl)sul...)
Affinity DataIC50:  0.870nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328363(1-(1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl...)
Affinity DataIC50:  0.960nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328372(5-chloro-1-((4-methoxy-3-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  1.10nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328365(4-fluoro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  1.10nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328406(6-chloro-3-(difluoromethyl)-1-((4-methoxy-3-(piper...)
Affinity DataIC50:  1.10nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328377(6-fluoro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  1.30nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328403(3-(difluoromethyl)-5,6-difluoro-1-((4-methoxy-3-(p...)
Affinity DataIC50:  1.40nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328371(5-chloro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  1.40nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328374(5-bromo-1-((4-methoxy-3-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50:  1.5nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328361(1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1...)
Affinity DataIC50:  1.70nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328368(1-((4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)sul...)
Affinity DataIC50:  2nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328370(5-fluoro-1-((4-methoxy-3-(4-methylpiperazin-1-yl) ...)
Affinity DataIC50:  2.10nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328373(5-bromo-1-((4-methoxy-3-(piperazin-1-yl)phenyl)sul...)
Affinity DataIC50:  2.10nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328375(1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1...)
Affinity DataIC50:  3.20nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM328369(5-fluoro-1-((4-methoxy-3-(piperazin-1-yl)phenyl)su...)
Affinity DataIC50:  3.5nMAssay Description:The binding affinity of the compound of this invention to human 5-HT6 receptor expressed in CHO cell was evaluated by radioligand binding assay as fo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: